IPF: clinical profiles

M. Selman (Mexico City, Mexico)

Source: Annual Congress 2010 - PG1 Core Curriculum Postgraduate Course: Idiopathic pulmonary fibrosis
Session: PG1 Core Curriculum Postgraduate Course: Idiopathic pulmonary fibrosis
Session type: Postgraduate Course
Number: 1
Disease area: Interstitial lung diseases

Slide presentationPDF journal article, handout or slidesMultimedia files

Rating: 4.5
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Selman (Mexico City, Mexico). IPF: clinical profiles. Annual Congress 2010 - PG1 Core Curriculum Postgraduate Course: Idiopathic pulmonary fibrosis

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
IPF: a morphological and biological entity
Source: Annual Congress 2010 - PG1 Core Curriculum Postgraduate Course: Idiopathic pulmonary fibrosis
Year: 2010



IPF and lung cancer: what are the links?
Source: Research Seminar 2010 - Novel insights in pulmonary fibrogenesis: from bench to bedside Research Seminar
Year: 2010

Challenges in IPF trials: the point on endpoints
Source: Annual Congress 2010 - Idiopathic pulmonary fibrosis: present understandings and future directions
Year: 2010

COPD: the link between gene-expression and the clinic
Source: Annual Congress 2010 - Phenotypic fingerprinting in asthma and COPD: systems biology is entering the clinic
Year: 2010


Clinical identification of CT-determined COPD phenotypes
Source: Annual Congress 2010 - Parenchmya and bronchial carcinoma
Year: 2010


Pirfenidone dose-response in patients with idiopathic pulmonary fibrosis (IPF): A comprehensive analysis of outcomes in CAPACITY 2
Source: Annual Congress 2010 - New insights in the treatment of idiopathic pulmonary fibrosis
Year: 2010

Near fatal asthma: Clinical and airway biopsy characteristics
Source: Annual Congress 2010 - Asthma and COPD: understanding through monitoring
Year: 2010

Genetic studies in asthma and COPD: what have we learned?
Source: Annual Congress 2011 - PG5 Asthma versus COPD: similarities and differences
Year: 2011



The diagnosis of IPF: recommendations & rationale
Source: Research Seminar 2010 - Novel insights in pulmonary fibrogenesis: from bench to bedside Research Seminar
Year: 2010


Clinically important phenotypes of COPD
Source: Annual Congress 2010 - PG8 Postgraduate Course: Phenotypes of asthma and COPD
Year: 2010



IPF: a distinct clinical entity?
Source: International Congress 2017 – State of the art session: "Interstitial lung disease and pulmonary vascular diseases"
Year: 2017


Novel patterns of serum biomarkers profiling using minimal important clinical outcomes (MICO) in the longidutinal study BODE cohort of COPD patients
Source: Annual Congress 2010 - COPD: symptoms and staging
Year: 2010


Therapeutic options for IPF
Source: Annual Congress 2010 - PG1 Core Curriculum Postgraduate Course: Idiopathic pulmonary fibrosis
Year: 2010



The long-term safety of pirfenidone in patients with idiopathic pulmonary fibrosis (IPF): Interim data from the RECAP extension study
Source: Annual Congress 2011 - New insights in the treatment of idiopathic pulmonary fibrosis
Year: 2011


The relationship between clinical prediction markers, radiological characteristics and 6 month outcome following acute pulmonary embolism
Source: Annual Congress 2010 - Clinical management of venous thrombosis, pulmonary embolism and thrombophilia
Year: 2010

How to define clinically relevant phenotypes and endotypes of asthma and COPD
Source: Annual Congress 2011 - PG11 Update of phenotypes of asthma and COPD
Year: 2011